|
|
||||||||
Second Department of Surgery, Fukui Medical University, Fukui 9101193, Japan
We
examined the role of matrix metalloproteinases (MMPs), tissue
inhibitors of MMP (TIMPs), and plasminogen activator (PA) in
transmyocardial laser revascularization (TMLR)-induced angiogenesis. TMLR was accomplished with a carbon dioxide laser in seven dogs whose
left anterior descending coronary artery (LAD) was ligated. Seven
control dogs underwent only LAD ligation, and four dogs underwent a
sham operation, consisting only of a left thoracotomy. Two weeks later,
transmural myocardial samples were harvested from the distributions of
the LAD and the left circumflex artery for substrate zymography,
immunohistochemical staining, and in situ zymography. MMP-1, MMP-2,
TIMP-1, TIMP-2, and urokinase-type PA levels in the distribution of the
LAD were higher in the laser group than in the control or sham group.
Counts of von Willebrand factor-positive microvessels and smooth muscle
-actin-positive arterioles demonstrated that the angiogenesis and
ateriogenesis was promoted in the laser group and correlated directly
with the number of MMP-stained microvessels. We conclude that TMLR
induces the expression of MMPs, TIMPs, and urokinase-type PA and that these proteinases play an important role in angiogenesis after TMLR.
matrix metalloproteinase
This article has been cited by other articles:
![]() |
D. Spiegelstein, C. Kim, Y. Zhang, G. Li, R. D. Weisel, R.-K. Li, and T. M. Yau Combined transmyocardial revascularization and cell-based angiogenic gene therapy increases transplanted cell survival Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3311 - H3316. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, K. Tanaka, A. Ihaya, Y. Fujibayashi, S. Takamatsu, K. Morioka, M. Sasaki, T. Uesaka, T. Kimura, N. Yamada, et al. Gene therapy for chronic myocardial ischemia using platelet-derived endothelial cell growth factor in dogs Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H408 - H415. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Christman, A. J. Vardanian, Q. Fang, R. E. Sievers, H. H. Fok, and R. J. Lee Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium J. Am. Coll. Cardiol., August 4, 2004; 44(3): 654 - 660. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |